You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

NEOMYCIN SULFATE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for neomycin sulfate and what is the scope of freedom to operate?

Neomycin sulfate is the generic ingredient in thirteen branded drugs marketed by Pharmacia And Upjohn, X Gen Pharms, Pfizer, Bristol Myers Squibb, Chartwell Molecular, Lannett, Lilly, Nostrum Labs Inc, Roxane, Sandoz, Teva, Xgen Pharms, Glaxosmithkline, Alcon, Watson Labs, Monarch Pharms, Allergan, Merck, Savage Labs, Fougera, and Pharmaderm, and is included in thirty-one NDAs. Additional information is available in the individual branded drug profile pages.

There are thirteen drug master file entries for neomycin sulfate. Four suppliers are listed for this compound.

Summary for NEOMYCIN SULFATE
US Patents:0
Tradenames:13
Applicants:21
NDAs:31
Drug Master File Entries: 13
Finished Product Suppliers / Packagers: 4
Raw Ingredient (Bulk) Api Vendors: 99
Clinical Trials: 11
Patent Applications: 6,989
What excipients (inactive ingredients) are in NEOMYCIN SULFATE?NEOMYCIN SULFATE excipients list
DailyMed Link:NEOMYCIN SULFATE at DailyMed
Recent Clinical Trials for NEOMYCIN SULFATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Huro Biotech Joint Stock CompanyN/A
Vietstar Biomedical ResearchN/A
Mahidol UniversityPhase 4

See all NEOMYCIN SULFATE clinical trials

Pharmacology for NEOMYCIN SULFATE
Medical Subject Heading (MeSH) Categories for NEOMYCIN SULFATE

US Patents and Regulatory Information for NEOMYCIN SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline NEOSPORIN neomycin sulfate; polymyxin b sulfate CREAM;TOPICAL 050176-002 Jan 14, 1985 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Alcon STATROL neomycin sulfate; polymyxin b sulfate SOLUTION/DROPS;OPHTHALMIC 062339-001 Nov 30, 1984 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Pharmacia And Upjohn NEO-DELTA-CORTEF neomycin sulfate; prednisolone acetate OINTMENT;OPHTHALMIC 061039-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Nostrum Labs Inc NEOMYCIN SULFATE neomycin sulfate TABLET;ORAL 065468-001 Mar 29, 2010 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Merck NEO-HYDELTRASOL neomycin sulfate; prednisolone sodium phosphate OINTMENT;OPHTHALMIC 050378-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Pharmaderm NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE neomycin sulfate; triamcinolone acetonide CREAM;TOPICAL 062595-001 Jul 21, 1986 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sandoz NEOMYCIN SULFATE neomycin sulfate TABLET;ORAL 061586-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.